| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |